Explore Island Pharmaceuticals’ Videos, Presentations, and Insights into Our Programs
Discover visual content showcasing our science, strategy, and development initiatives.
Stockhead
Long Shortz with Island Pharmaceuticals: Ebola, Marburg and Dengue clinical programs advance
Stockhead
Long Shortz with Island Pharmaceuticals: Ebola, Marburg and Dengue clinical programs advance
Stockhead
Break it Down: Island expands US biodefence engagement ahead of Galidesivir studies
Stockhead
Break it Down: Island expands US biodefence engagement ahead of Galidesivir studies
Investor Stream
Dr. Daniel Tillett Says Next 12–18 Months Could Be Pivotal for Island Pharmaceuticals
Investor Stream
Dr. Daniel Tillett Says Next 12–18 Months Could Be Pivotal for Island Pharmaceuticals
Investor Stream
US Army USAMRIID Partnership Could Fast Track Galidesivir for Marburg Virus
Investor Stream
US Army USAMRIID Partnership Could Fast Track Galidesivir for Marburg Virus
Investor Stream
ASX Defence Exposure Surging as Global Tensions Ignite a Multi Year Investment Boom
Investor Stream
ASX Defence Exposure Surging as Global Tensions Ignite a Multi Year Investment Boom
Investor Stream
Island Pharmaceuticals (ASX:ILA) Investor Webinar: Combatting Urgent Viral Disease Threats
Investor Stream
Island Pharmaceuticals (ASX:ILA) Investor Webinar: Combatting Urgent Viral Disease Threats
Investor Stream
Island Pharma’s ISLA-101 Shows Success in Human Trial for Dengue – Phase 2 Results
Investor Stream
Island Pharma’s ISLA-101 Shows Success in Human Trial for Dengue – Phase 2 Results
Market Open
Island Pharmaceuticals Acquires Galidesivir: A Major Step in Infectious Disease Drug Development
Market Open
Island Pharmaceuticals Acquires Galidesivir: A Major Step in Infectious Disease Drug Development
Stocks Down Under
Island Pharmaceuticals (ASX: ILA) received great data in its Phase 2a study of ILA-101 in dengue.
Stocks Down Under
Island Pharmaceuticals (ASX: ILA) received great data in its Phase 2a study of ILA-101 in dengue.
Market Open
Island Pharmaceuticals: Tackling Global Viral Threats with Drug Repurposing | ASX:ILA
Market Open
Island Pharmaceuticals: Tackling Global Viral Threats with Drug Repurposing | ASX:ILA
Investor Hub
David Foster (ASX:ILA) and Ben Williamson interview | InvestorHub at Ignite Investment Summit
Investor Hub
David Foster (ASX:ILA) and Ben Williamson interview | InvestorHub at Ignite Investment Summit
Investor Stream
What makes Island Pharmaceuticals (ASX:ILA) an enticing investment proposition
Investor Stream
What makes Island Pharmaceuticals (ASX:ILA) an enticing investment proposition